Your browser is no longer supported. Please, upgrade your browser.
Settings
OVAS OvaScience, Inc. daily Stock Chart
OVAS [NASD]
OvaScience, Inc.
Index- P/E- EPS (ttm)-2.21 Insider Own0.90% Shs Outstand35.91M Perf Week-2.27%
Market Cap46.32M Forward P/E- EPS next Y-1.26 Insider Trans0.00% Shs Float33.35M Perf Month-15.96%
Income-75.40M PEG- EPS next Q-0.41 Inst Own67.90% Short Float16.32% Perf Quarter-16.77%
Sales0.60M P/S77.21 EPS this Y5.30% Inst Trans7.49% Short Ratio6.96 Perf Half Y-66.92%
Book/sh2.66 P/B0.48 EPS next Y20.30% ROA-56.90% Target Price1.00 Perf Year-81.39%
Cash/sh2.76 P/C0.47 EPS next 5Y- ROE-62.90% 52W Range1.26 - 8.98 Perf YTD-15.69%
Dividend- P/FCF- EPS past 5Y3.10% ROI-75.10% 52W High-85.63% Beta3.59
Dividend %- Quick Ratio9.60 Sales past 5Y- Gross Margin- 52W Low2.38% ATR0.07
Employees118 Current Ratio9.60 Sales Q/Q0.00% Oper. Margin- RSI (14)30.01 Volatility5.80% 5.12%
OptionableYes Debt/Eq0.00 EPS Q/Q47.60% Profit Margin- Rel Volume0.24 Prev Close1.31
ShortableYes LT Debt/Eq0.00 EarningsMay 09 AMC Payout- Avg Volume782.29K Price1.29
Recom3.00 SMA20-7.14% SMA50-15.47% SMA200-61.62% Volume190,979 Change-1.53%
Apr-18-17Resumed Credit Suisse Underperform
Jan-25-16Downgrade Oppenheimer Outperform → Perform
Jan-21-16Initiated Credit Suisse Underperform
Nov-09-15Downgrade Leerink Partners Outperform → Mkt Perform
Oct-21-15Reiterated Oppenheimer Outperform $12 → $16
Sep-30-15Reiterated Oppenheimer Outperform $60 → $12
Sep-29-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-29-15Initiated JP Morgan Neutral $40
Jan-21-15Reiterated Oppenheimer Outperform $55 → $60
Dec-24-14Upgrade Oppenheimer Perform → Outperform
Dec-18-14Reiterated H.C. Wainwright Buy $40 → $100
Nov-11-14Reiterated H.C. Wainwright Buy $16 → $40
Oct-08-14Downgrade Oppenheimer Outperform → Perform $11
Apr-29-14Initiated Oppenheimer Outperform $11
May-23-17 10:32AM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm PR Newswire
May-22-17 04:55PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in OvaScience, Inc. to Contact the Firm Accesswire
May-10-17 07:16AM  Edited Transcript of OVAS earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-09-17 05:32PM  OvaScience reports 1Q loss Associated Press
04:02PM  OvaScience Reports First Quarter 2017 Financial Results Business Wire
May-05-17 01:22PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm PR Newswire
May-04-17 10:36AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) and Lead Plaintiff Deadline - May 29, 2017 Accesswire
May-02-17 04:13PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
03:14PM  DEADLINE ALERT: Brower Piven Alerts Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Those with Losses in Excess of $100,000 from Investment in OvaScience, Inc. to Contact the Firm Business Wire
Apr-19-17 05:37PM  SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit Against OvaScience, Inc. Business Wire
04:42PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In OvaScience, Inc. To Contact The Firm PR Newswire
Apr-12-17 02:05PM  Screening for Net-Net Stocks in an Overvalued Market GuruFocus.com
Apr-10-17 07:17PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
06:26PM  Robbins Arroyo LLP: OvaScience, Inc. (OVAS) Misled Shareholders According to a Recently Filed Class Action Business Wire
Apr-05-17 10:43AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -7.27%
10:43AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
09:30AM  Zacks.com featured highlights: EV Energy Partners, OvaScience, Galena Biopharma, Amaya and Cenovus Energy Zacks
09:30AM  Zacks.com featured highlights: EV Energy Partners, OvaScience, Galena Biopharma, Amaya and Cenovus Energy
Apr-04-17 10:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire -5.17%
10:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Mar-31-17 11:06AM  INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against OvaScience, Inc. Business Wire
10:55AM  Edited Transcript of OVAS earnings conference call or presentation 2-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
10:55AM  Edited Transcript of OVAS earnings conference call or presentation 2-Mar-17 9:30pm GMT
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - May 29, 2017 PR Newswire
Mar-30-17 08:01PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against OvaScience, Inc. and Encourages Investors With Losses to Contact the Firm Business Wire
06:30PM  IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchasers of OvaScience, Inc. GlobeNewswire
06:30PM  IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchasers of OvaScience, Inc.
Mar-29-17 04:52PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. (OVAS) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
Mar-28-17 12:07PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In OvaScience, Inc. To Contact The Firm GlobeNewswire
Mar-27-17 10:42PM  Lifshitz & Miller LLP Files Class Action Lawsuit against OvaScience, Inc. PR Newswire +11.70%
04:02PM  ETFs with exposure to OvaScience, Inc. : March 27, 2017
Mar-24-17 06:50AM  OvaScience (OVAS) Shares March Higher, Can It Continue?
Mar-23-17 09:30AM  Biocept and OvaScience Post Gains Amid Investor Speculation Accesswire
08:20AM  OvaScience, Inc. (OVAS) Looks Good: Stock Up 9.6% Higher
Mar-21-17 11:35AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
Mar-15-17 01:59PM  OvaScience, Inc. :OVAS-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-08-17 01:04PM  OVASCIENCE, INC. Financials
Mar-02-17 04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:23PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:18PM  OvaScience reports 4Q loss
04:06PM  OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results Business Wire
07:07AM  Q4 2016 OvaScience Inc Earnings Release - After Market Close
Feb-27-17 04:01PM  OvaScience to Present at Upcoming Investor Conferences in March Business Wire
Feb-23-17 04:01PM  OvaScience to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call Business Wire
Feb-17-17 05:11PM  Lifshitz & Miller LLP Announces Investigation of BT Group plc, Celadon Group, Inc., Community Health Systems, Inc., Dimension Therapeutics, Inc., Home Capital Group Inc., Lifevantage Corporation, OvaScience, Inc. and Under Armour, Inc. PR Newswire
Feb-15-17 03:03PM  5 Ways Allergan Can Keep Up Momentum
Feb-14-17 12:57PM  Newman Ferrara LLP Announces Corporate Governance Investigation of OvaScience, Inc. Business Wire
Jan-13-17 02:00PM  Troubled fertility biotech OvaScience offers CFO cash bonus not to leave at bizjournals.com
Jan-10-17 06:03AM  OVASCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure
Jan-05-17 04:02PM  OvaScience to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire -6.29%
Dec-27-16 07:18AM  Implied Volatility Surging for OvaScience (OVAS) Stock Options
Dec-23-16 05:01PM  OVASCIENCE, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Princi
04:05PM  OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Dec-22-16 04:04PM  Abercrombie, OvaScience Slide Into Thursdays 52-Week Low Club at 24/7 Wall St. -54.88%
06:25AM  Fertility-focused biotech OvaScience cuts 30% of workforce, new CEO resigns at bizjournals.com
Dec-21-16 04:55PM  OvaScience loses almost a third of its value amid massive layoffs, changes at MarketWatch
04:04PM  OvaScience Announces Business Update Business Wire
Dec-13-16 01:19PM  ETFs with exposure to OvaScience, Inc. : December 13, 2016
03:45AM  Is Agilysys, Inc. (AGYS) a Good Stock to Buy? at Insider Monkey
Dec-07-16 11:13AM  OvaScience Inc (OVAS): Hedge Fund Sentiment Flatlines at Insider Monkey -9.34%
Dec-02-16 12:59PM  ETFs with exposure to OvaScience, Inc. : December 2, 2016
Nov-30-16 08:55AM  Can OvaScience (OVAS) Keep the Earnings Streak Alive This Quarter?
Nov-23-16 02:08PM  Edited Transcript of OVAS earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-21-16 08:38AM  OvaScience (OVAS) Enters Oversold Territory
Nov-11-16 01:26PM  These 5 Stocks Under $10 Could Make You a Lot of Money
Nov-10-16 12:50PM  ETFs with exposure to OvaScience, Inc. : November 10, 2016
Nov-08-16 10:48AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 -8.31%
Nov-03-16 05:13PM  OvaScience reports 3Q loss -6.80%
04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:09PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  OvaScience Reports Third Quarter 2016 Financial Results Business Wire
07:07AM  Q3 2016 OvaScience Inc Earnings Release - After Market Close
Oct-31-16 04:02PM  OvaScience to Present at the 25th Annual Credit Suisse Healthcare Conference Business Wire
Oct-27-16 04:01PM  OvaScience to Host Third Quarter 2016 Financial Results Conference Call Business Wire -5.72%
Oct-12-16 02:33PM  Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD
Sep-27-16 10:13AM  ETFs with exposure to OvaScience, Inc. : September 27, 2016
Sep-20-16 08:58AM  OvaScience (OVAS) Shares March Higher, Can It Continue?
Sep-15-16 10:27AM  ETFs with exposure to OvaScience, Inc. : September 15, 2016
Sep-14-16 04:05PM  OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Sep-06-16 05:01PM  OVASCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:05PM  OvaScience Announces Executive Management Changes and Appointments to Further Drive Companys Growth Business Wire
Aug-31-16 08:30AM  OvaScience to Present at Upcoming Investor Conferences in September Business Wire
Aug-29-16 06:00AM  OvaSciences AUGMENT Treatment Commercially Available in Japan Through Partnership with IVF JAPAN GROUP Business Wire +6.49%
Aug-26-16 10:39AM  ETFs with exposure to OvaScience, Inc. : August 26, 2016
Aug-15-16 10:41AM  ETFs with exposure to OvaScience, Inc. : August 15, 2016
10:20AM  Edited Transcript of OVAS earnings conference call or presentation 4-Aug-16 8:30pm GMT
Aug-12-16 12:56PM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 02:31AM  Can The Uptrend Continue for OvaScience (OVAS)?
Aug-04-16 05:29PM  OvaScience reports 2Q loss
04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:15PM  OVASCIENCE, INC. Files SEC form 10-Q, Quarterly Report
04:07PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  OvaScience Reports Second Quarter 2016 Financial Results Business Wire
07:07AM  Q2 2016 OvaScience Inc Earnings Release - After Market Close
Jul-28-16 04:05PM  OvaScience to Host Second Quarter 2016 Financial Results Conference Call Business Wire -5.66%
Jul-01-16 08:19AM  OVASCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +7.10%
07:00AM  Harald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience Business Wire
Jun-17-16 08:00AM  OvaScience to Present at the JMP Securities Life Sciences Conference Business Wire
Jun-03-16 04:21PM  OVASCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -5.42%
04:05PM  OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women worldwide. The company's patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It engages in developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize the fertility treatment consisting of AUGMENT to enhance the energy and health of the woman's eggs by using mitochondria from a woman's EggPC cells; OvaTure to produce mature fertilizable eggs from a woman's own EggPC cells without the need for hormone injections; OvaPrime treatment is used to replenish a woman's egg reserve by transferring the EggPCs from woman's own ovaries; and OvaXon for the prevention of inherited human disease and improvement of animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dipp MichelleChief Executive OfficerJun 01Buy7.00425,0002,975,000962,056Jun 03 04:24 PM
ALDRICH RICHARDDirectorJun 01Buy7.00425,0002,975,000962,056Jun 03 04:25 PM